These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 33164299)
21. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center. Rosenbaum E; Antonescu CR; Smith S; Bradic M; Kashani D; Richards AL; Donoghue M; Kelly CM; Nacev B; Chan JE; Chi P; Dickson MA; Keohan ML; Gounder MM; Movva S; Avutu V; Thornton K; Zehir A; Bowman AS; Singer S; Tap W; D'Angelo S J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365586 [TBL] [Abstract][Full Text] [Related]
22. Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment. Park C; Kim M; Kwak Y; Moon KC; Kim SH; Keam B; Kim YJ; Kim TM; Kim DW Cancer Res Treat; 2021 Oct; 53(4):1195-1203. PubMed ID: 33540493 [TBL] [Abstract][Full Text] [Related]
23. Angiosarcoma of the breast: a rare clinicopathological entity. Biswas T; Tang P; Muhs A; Ling M Am J Clin Oncol; 2009 Dec; 32(6):582-6. PubMed ID: 19581792 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of taxane regimens in patients with metastatic angiosarcoma. Hirata T; Yonemori K; Ando M; Hirakawa A; Tsuda H; Hasegawa T; Chuman H; Namikawa K; Yamazaki N; Fujiwara Y Eur J Dermatol; 2011; 21(4):539-45. PubMed ID: 21697045 [TBL] [Abstract][Full Text] [Related]
25. Molecular and immune pathobiology of human angiosarcoma. Lim RMH; Lee JY; Kannan B; Ko TK; Chan JY Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189159. PubMed ID: 39032539 [TBL] [Abstract][Full Text] [Related]
26. Angiosarcoma: clinical and imaging features from head to toe. Gaballah AH; Jensen CT; Palmquist S; Pickhardt PJ; Duran A; Broering G; Elsayes KM Br J Radiol; 2017 Jul; 90(1075):20170039. PubMed ID: 28471264 [TBL] [Abstract][Full Text] [Related]
27. Primary Breast Angiosarcoma: Comparative Transcriptome Analysis. Rincón-Riveros A; De la Peña J; Rubiano W; Olivella F; Martinez-Agüero M; Villegas VE Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555675 [TBL] [Abstract][Full Text] [Related]
28. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma. Loh JW; Lee JY; Lim AH; Guan P; Lim BY; Kannan B; Lee ECY; Gu NX; Ko TK; Ng CC; Lim JCT; Yeong J; Lim JQ; Ong CK; Teh BT; Chan JY Commun Biol; 2023 Apr; 6(1):461. PubMed ID: 37106027 [TBL] [Abstract][Full Text] [Related]
29. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression. Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment. Maeda-Otsuka S; Kajihara I; Tasaki Y; Yamada-Kanazawa S; Sakamoto R; Sawamura S; Masuzawa M; Masuzawa M; Amoh Y; Hoshina D; Abe R; Komohara Y; Ihn H J Dermatol Sci; 2019 Feb; 93(2):123-132. PubMed ID: 30704938 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology, tumor characteristics and survival in patients with angiosarcoma in the United States: a population-based study of 4537 cases. Zhang C; Xu G; Liu Z; Xu Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Mao M; Wang X; Wang G; Zhang C Jpn J Clin Oncol; 2019 Dec; 49(12):1092-1099. PubMed ID: 31612920 [TBL] [Abstract][Full Text] [Related]
32. Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases. Abedalthagafi M; Rushing EJ; Auerbach A; Desouki MM; Marwaha J; Wang Z; Fanburg-Smith JC Ann Diagn Pathol; 2010 Feb; 14(1):15-22. PubMed ID: 20123452 [TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs. Suchak R; Thway K; Zelger B; Fisher C; Calonje E Am J Surg Pathol; 2011 Jan; 35(1):60-9. PubMed ID: 21164288 [TBL] [Abstract][Full Text] [Related]
34. Cutaneous angiosarcoma: a case series with prognostic correlation. Morgan MB; Swann M; Somach S; Eng W; Smoller B J Am Acad Dermatol; 2004 Jun; 50(6):867-74. PubMed ID: 15153886 [TBL] [Abstract][Full Text] [Related]
35. [Characteristics and outcomes of primary angiosarcoma]. Zhang ZY; Cheng YJ; Gong XL; Ge YP; Bai CM; Wang XJ; Miao Q; Zhang FQ Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):693-697. PubMed ID: 31550860 [No Abstract] [Full Text] [Related]
36. SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma. Chosokabe M; Noguchi A; Hoshikawa M; Masuzawa M; Takagi M Anticancer Res; 2019 Mar; 39(3):1143-1150. PubMed ID: 30842143 [TBL] [Abstract][Full Text] [Related]
37. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases. Fanburg-Smith JC; Furlong MA; Childers EL Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107 [TBL] [Abstract][Full Text] [Related]
38. A pooled analysis of primary hepatic angiosarcoma. Zeng D; Cheng J; Gong Z; Chen J; Long H; Zhu B Jpn J Clin Oncol; 2020 May; 50(5):556-567. PubMed ID: 32083280 [TBL] [Abstract][Full Text] [Related]
39. Schwannoma with angiosarcoma. Report of a case and comparison with other types of nerve tumors with angiosarcoma. Rückert RI; Fleige B; Rogalla P; Woodruff JM Cancer; 2000 Oct; 89(7):1577-85. PubMed ID: 11013374 [TBL] [Abstract][Full Text] [Related]
40. Immunohistological distribution of stem cell factor and kit receptor in angiosarcoma. Yamamoto T; Umeda T; Nishioka K Acta Derm Venereol; 2000; 80(6):443-5. PubMed ID: 11243641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]